期刊
INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 11, 期 -, 页码 3077-3086出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S106625
关键词
RNA therapeutics; siRNA; mRNA; lipid nanoparticle; targeted delivery; clinical trial
资金
- Russian Scientific Foundation [14-34-00017]
- Russian Science Foundation [14-34-00017] Funding Source: Russian Science Foundation
This review covers the basic aspects of small interfering RNA delivery by lipid nanoparticles (LNPs) and elaborates on the current status of clinical trials for these systems. We briefly describe the roles of all LNP components and possible strategies for their improvement. We also focus on the current clinical trials using LNP-formulated RNA and the possible outcomes for therapy in the near future. Also, we present a critical analysis of selected clinical trials that reveals the common logic behind target selection. We address this review to a wide audience, especially to medical doctors who are interested in the application of RNA interference-based treatment platforms. We anticipate that this review may spark interest in this particular audience and generate new ideas in target selection for the disorders they are dealing with.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据